[1] Khor B, Snow M, Herrman E, et al. Interconnections between the oral and gut microbiomes: reversal of microbial dysbiosis and the balance between systemic health and disease [J]. Microorganisms, 2021, 9(3): 496. [2] Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body [J]. Protein Cell, 2010, 1(8): 718-725. [3] Hays KE, Pfaffinger JM, Ryznar R. The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease [J]. Gut Microbes, 2024, 16(1): 2393270. [4] Leonov GE, Varaeva YR, Livantsova EN, et al. The complicated relationship of short-chain fatty acids and oral microbiome: a narrative review [J]. Biomedicines, 2023, 11(10): 2749. [5] Liu C, Ruan F, Chen Z, et al. Phenanthrene-induced hyperuricemia with intestinal barrier damage and the protective role of theabrownin: Modulation by gut microbiota-mediated bile acid metabolism [J]. Sci Total Environ, 2024, 949: 174923. [6] Khoshbin K, Camilleri M. Effects of dietary components on intestinal permeability in health and disease [J]. Am J Physiol Gastrointest Liver Physiol, 2020, 319(5): G589-G608. [7] Zhao Y, Liu Y, Jia L. Gut microbial dysbiosis and inflammation: impact on periodontal health [J]. J Periodontal Res, 2024, 60(1): 30-43. [8] Deo PN, Deshmukh R. Oral microbiome: Unveiling the fundamentals [J]. J Oral Maxillofac Pathol, 2019, 23(1): 122-128. [9] Bao J, Li L, Zhang Y, et al. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota [J]. Int J Oral Sci, 2022, 14(1): 32. [10] Lu Y, Li Z, Peng X. Regulatory effects of oral microbe on intestinal microbiota and the illness [J]. Front Cell Infect Microbiol, 2023, 13: 1093967. [11] Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with toothbrushing and dental extraction [J]. Circulation, 2008, 117(24): 3118-3125. [12] Castillo DM, Sánchez-Beltrán MC, Castellanos JE, et al. Detection of specific periodontal microorganisms from bacteraemia samples after periodontal therapy using molecular-based diagnostics [J]. J Clin Periodontol, 2011, 38(5): 418-427. [13] Deng J, Lu C, Zhao Q, et al. The Th17/Treg cell balance: crosstalk among the immune system, bone and microbes in periodontitis [J]. J Periodontal Res, 2022, 57(2): 246-255. [14] Zhou T, Xu W, Wang Q, et al. The effect of the “Oral-Gut” axis on periodontitis in inflammatory bowel disease: a review of microbe and immune mechanism associations [J]. Front Cell Infect Microbiol, 2023, 13: 1132420. [15] Nagao JI, Kishikawa S, Tanaka H, et al. Pathobiont-responsive Th17 cells in gut-mouth axis provoke inflammatory oral disease and are modulated by intestinal microbiome [J]. Cell Rep, 2022, 40(10): 111314. [16] Shaffer M, Lozupone C. Prevalence and source of fecal and oral bacteria on Infant, child, and adult hands [J]. mSystems, 2018, 3(1): e00192-17. [17] Qian J, Yang M, Xu D, et al. Alterations of the salivary microbiota in gastroesophageal reflux disease [J]. J Oral Biosci, 2023, 65(4): 280-286. [18] Liu H, Hong XL, Sun TT, et al. Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation [J]. J Dig Dis, 2020, 21(7): 385-398. [19] Bai J, Tian Y, Lu Y, et al. Differential effects of high-fat diet on salivary and gut microbiota [J]. Front Cell Infect Microbiol, 2025, 15: 1547555. [20] Yan J, Herzog JW, Tsang K, et al. Gut microbiota induce IGF-1 and promote bone formation and growth [J]. Proc Natl Acad Sci U S A, 2016, 113(47): E7554-E7563. [21] Tyagi AM, Yu M, Darby TM, et al. The microbial metabolite butyrate stimulates bone formation via T tegulatory cell-mediated regulation of WNT10B expression [J]. Immunity, 2018, 49(6): 1116-1131.e7. [22] Liu J, Wang Y, Meng H, et al. Butyrate rather than LPS subverts gingival epithelial homeostasis by downregulation of intercellular junctions and triggering pyroptosis [J]. J Clin Periodontol, 2019, 46(9): 894-907. [23] Kirkik D, Kalkanli Tas S, Tanoglu A. Unraveling the blood microbiome: novel insights into inflammasome responses in Crohn’s disease [J]. Eur J Gastroen Hepat, 2024, 36(8): 975-984. [24] Wang X, Xiong K, Huang F, et al. A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide [J]. Front Immunol, 2022, 13: 1018567. [25] Shishniashvili T, Suladze T, Makhviladze M, et al. Dental diseases and intestinal dysbiosis among children [J]. J Clin Pediatr Dent, 2018, 42(3): 217-220. [26] Xu L, Wang Y, Wu Z, et al. Salivary microbial community alterations due to probiotic yogurt in preschool children with healthy deciduous teeth [J]. Arch Microbiol, 2021, 203(6): 3045-3053. [27] Kashyap B, Hyvärinen E, Kullaa AM. Salivary short-chain fatty acids (SCFAs) are viable predictors of early changes in systemic health [J]. Chin J Dent Res, 2024, 27(3): 193-202. [28] Luo S, Li W, Li Q, et al. Causal effects of gut microbiota on the risk of periodontitis: a two-sample Mendelian randomization study [J]. Front Cell Infect Microbiol, 2023, 13: 1160993. [29] Lv J, Liu Y, Jia S, et al. Carbon monoxide-releasing molecule-3 suppresses tumor necrosis factor-α- and interleukin-1β- induced expression of junctional molecules on human gingival fibroblasts via the heme oxygenase-1 pathway [J]. Mediators Inflamm, 2020, 2020: 6302391. [30] Yuan X, Zhou F, Wang H, et al. Systemic antibiotics increase microbiota pathogenicity and oral bone loss [J]. Int J Oral Sci, 2023, 15(1): 4. [31] Zhang Y, Zhu C, Cao G, et al. Dynamic alterations of oral microbiota related to halitosis in preschool children [J]. Front Cell Infect Microbiol, 2021, 11: 599467. [32] Qian XX. The association of extra-oral halitosis with small intestinal bacterial overgrowth in inflammatory bowel disease [J]. Inflamm Bowel Dis, 2024, 30(6): 1053-1054. [33] Jin B, Wang P, Liu P, et al. Genetic connectivity of gut microbiota and oral ulcers: a mendelian randomization study [J]. Int Dent J, 2024, 74(4): 696-704. [34] Liu Z, Lu M, Wang W, et al. Anxiety and small intestinal bacterial overgrowth: associations with recurrent aphthous ulcers [J]. BMC Oral Health, 2025, 25(1): 688. [35] Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal manifestations of inflammatory bowel disease: current Cconcepts, treatment, and implications for disease management [J]. Gastroenterology, 2021, 161(4): 1118-1132. [36] Finamore A, Peluso I, Cauli O. Salivary stress/immunological markers in Crohn’s disease and ulcerative colitis [J]. Int J Mol Sci, 2020, 21(22): 8562. [37] Wan Z, Zheng J, Zhu Z, et al. Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health [J]. Front Nutr, 2022, 9: 1031502. [38] Al-Qadami G, Verma G, Van Sebille Y, et al. Antibiotic-induced gut microbiota depletion accelerates the recovery of radiation-induced oral mucositis in rats [J]. Int J Radiat Oncol Biol Phys, 2022, 113(4): 845-858. [39] Liu X, Li X, Xie M, et al. Association of gut microbiome and oral cavity cancer: A two sample mendelian randomization and case-control study [J]. J Stomatol Oral Maxillofac Surg, 2024, 125(4): 101736. [40] Kaźmierczak-Siedlecka K, Dvořák A, Folwarski M, et al. Fungal gut microbiota dysbiosis and its role in colorectal, oral, and pancreatic carcinogenesis [J]. Cancers, 2020, 12(5): 1326. [41] Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application [J]. Int Immunol, 2007, 19(7): 813-824. [42] Kim SV, Xiang WV, Kwak C, et al. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa [J]. Science, 2013, 340(6139): 1456-1459. [43] OmerOglou E, Karaca B, Kibar H, et al. The role of microbiota-derived postbiotic mediators on biofilm formation and quorum sensing-mediated virulence of Streptococcus mutans: A perspective on preventing dental caries [J]. Microb Pathog, 2022, 164: 105390. [44] Twetman S, Belstrøm D. Effect of synbiotic and postbiotic supplements on dental caries and periodontal diseases-a comprehensive review [J]. Int J Environ Res Public Health, 2025, 22(1): 72. [45] Han HS, Yum H, Cho YD, et al. Improvement of halitosis by probiotic bacterium Weissella cibaria CMU: a randomized controlled trial [J]. Front Microbiol, 2023, 14: 1108762. [46] Frey-Furtado L, Magalhães I, Azevedo MJ, et al. The role of biotics as a therapeutic strategy for oral mucositis-a systematic review [J]. Probiotics Antimicrob Proteins, 2024, 16(4): 1313-1326. [47] Jayasinghe T, Jenkins J, Medara N, et al. Dietary fibre modulates body composition, blood glucose, inflammation, microbiome, and metabolome in a murine model of periodontitis [J]. Nutrients, 2025, 17(7): 1146. [48] Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice [J]. Diabetes, 2008, 57(6): 1470-1481. [49] Imdad A, Pandit NG, Zaman M, et al. Fecal transplantation for treatment of inflammatory bowel disease [J]. Cochrane Database Syst Rev, 2023, 11(11): CD012774. [50] Lindo CE, Sebastian J, Kuntjoro KN, et al. Microbiota transplantation as an adjunct to standard periodontal treatment in periodontal disease: a systematic review [J]. Medicina (Kaunas), 2024, 60(4): 672. [51] Emencheta SC, Olovo CV, Eze OC, et al. The role of bacteriophages in the gut microbiota: implications for human health [J]. Pharmaceutics, 2023, 15(10): 2416. [52] Chen Z, Guo Z, Lin H, et al. The feasibility of phage therapy for periodontitis [J]. Future Microbiol, 2021, 16: 649-656. |